CNC Centene Corp
Company Analysis
Latest News
🔴 Centene is trading 4.3% down today as healthcare and broader markets fall
Centene is trading 4.3% lower at $72.75, with no new company-specific catalyst surfaced; the decline appears more consistent with sector and market pressure. -...
🟢 Centene is trading 10% up today as election outcome lifts Medicaid and ACA expectations
Centene is trading at $74.47 (+10.36%) as Democrats’ control of both congressional chambers lifts expectations for a more favorable Medicaid and ACA policy...
🟢 Centene is trading 7.2% up today on election optimism for Medicaid and ACA insurers
Centene is trading 7.2% up at $72.34, amid election-related optimism for health insurers following Democrats’ control of both congressional chambers. - A...
🟢 Centene is trading 4.43% up in pre-market — catalyst remains unclear
Centene is trading at $70.47, up 4.43%, with no clear catalyst identified. - No clear Centene-specific announcement explaining the November 4 pre-market gain...
🔴 Centene is trading 4.18% down with no clear catalyst reported
Centene is trading at $65.59, down 4.18%, with no clear new company-specific catalyst for the November 2 decline in available reporting. - Truist raised its...
Centene Records $263 Million in Severance Costs to Cut Expenses
Centene recorded $263 million in severance costs in the third quarter, primarily tied to a voluntary employee buyout program intended to reduce expenses. Total...
🟢 Centene is trading 4.22% up today after Q3 earnings beat and guidance raise
Centene is trading 4.22% up at $70.90 after reporting third-quarter 2026 adjusted earnings of $0.58 per share, well above the $0.10 analyst estimate. - Raised...
Centene beats third quarter 2026 estimates and raises full-year adjusted EPS guidance floor to $5.20
Centene reported third quarter 2026 revenue of $50.6 billion and adjusted EPS of $0.58, significantly outperforming analyst expectations. The company raised...
Centene Corp Q3 2026 Earnings Preview: What Analysts Expect on October 27, 2026
Centene is expected to report Q3 2026 revenue of $47.11 billion and adjusted earnings of $0.07 per share, with its current price of $70.20 sitting just below...
🔴 Centene is trading 9.09% down in after-hours trading — no verified company-specific catalyst
Centene is trading 9.09% down at $62.40 after hours, with no verified company-specific announcement explaining the move. - The regular-session close was...
Centene Shares Jump on National Gold Card Program Set for November 2026
Centene shares rose as much as 3.5% during the trading session after the company announced a national Gold Card program. The stock closed up 2.8% and reached a...
🔴 Centene is trading 41.12% down in after-hours trading amid a potentially erroneous quote
Centene is trading 41.12% down at $37.26; the extreme after-hours move appears unconfirmed and may reflect an illiquid or erroneous quote. - Centene closed at...
🟢 Centene is trading 5% up today — no clear company-specific catalyst identified
Centene is trading 5.1% up at $67.33, with no clear company-specific catalyst identified for the September 10, 2026 gain. - A September 9 report said the U.S....
🔴 Centene is trading 4.1% down today as investors assess insurance-coverage and ACA-subsidy risks
Centene is trading 4.1% down at $61.94 amid a broader healthcare-sector sell-off as investors assess insurance-coverage and ACA-subsidy risks. • Centene’s...
🟢 Centene is trading 4% up today as healthcare-sector sentiment strengthens on medical-device earnings
Centene is trading 4.02% up at $67.85 as healthcare-sector sentiment strengthened on positive medical-device earnings and a going-private proposal for...
🔴 Centene is trading 4.12% down today after announcing CFO succession
Centene is trading 4.12% down at $64.69 after CFO Andrew Asher’s December 2026 step-down and end-2027 retirement announcement. - Christopher Neczypor,...
Centene Announces CFO Transition and Reaffirms Full-Year 2026 EPS Guidance
Centene Corporation announced that Chief Financial Officer Andrew Asher will retire at the end of 2026, with Christopher Neczypor, former CFO of Lincoln...
🔴 Centene is trading 4.02% down today amid possible enrollment and cost concerns
Centene is trading at $64.30, with a -4.02% change as investors may be reassessing enrollment and cost concerns. - The decline reverses part of the 4.56% gain...
🟢 Centene is trading 4.3% up today as robust earnings and raised guidance fuel a multi-day rally
Centene is trading 4.3% up today at $66.85, extending a multi-day rally driven by robust recent earnings and raised guidance that bolstered investor...
Centene Faces Surging Churn Risk, Following End of Medicare Part D Subsidies
Centene faces a significant risk of customer churn in its standalone Medicare Part D prescription drug plans. This follows the federal government’s decision to...